Dr. Michael Snyder

And then we brought in the wearables when they were first fitness trackers.

We thought, well, maybe they're a little more interesting than just fitness trackers.

So we put them on for health monitoring.

And I can tell when we started, it was a bit controversial at the time.

A lot of the physicians are not like sequencing the genomes of healthy people.

This shows when we – it was right after genome sequencing was first coming out.

And they were worried we were going to turn everybody into hypochondriacs, going to cost millions of dollars.

And most people have warmed up to it now, not 100%.

A lot of people still don't like that.

They still don't like the wearables.

I'm sure we'll talk about that.

But anyway, we did show that a lot of people learned some pretty important things from the genome.

One young guy turned out, he had a mutation of heart gene and his father died right around the time we sequenced his genome.

His father died of a heart problem.

And sure enough, he has a heart defect that was uncovered by genome sequence.

So we had examples like that.

And then same with the wearables, uncovered things, all kinds of things popped up.

Actually, 49 people had what we would call major health discovery just in the first three and a half years of running the study.

With all kinds of things.

That was the thing.